68Ga-PSMA PET/CT显像在多发性骨髓瘤中的应用
68Ga-PSMA PET/CT Imaging in Multiple Myeloma.
PubMed 文献 · Clin Nucl Med · 2017-01-01
本文描述68Ga-PSMA PET/CT在多发性骨髓瘤显像中的应用,病灶对该示踪剂摄取强烈,其机制可能为肿瘤新生血管形成;
要点
- 68Ga-PSMA PET/CT可用于多发性骨髓瘤病灶显像,病灶摄取强烈。
- 非前列腺恶性肿瘤中68Ga-PSMA摄取增高可能归因于肿瘤新生血管形成。
核心结论
- 68Ga-PSMA PET/CT可用于多发性骨髓瘤显像,病灶对68Ga-PSMA摄取强烈。
- 非前列腺恶性肿瘤中68Ga-PSMA摄取增高的机制可能为肿瘤新生血管形成。
研究设计与样本
- 本文为病例报告,描述68Ga-PSMA PET/CT在多发性骨髓瘤显像中的应用,未报告样本量与具体病例数。
主要发现
- 多发性骨髓瘤病灶对68Ga-PSMA摄取强烈。
- 非前列腺恶性肿瘤中68Ga-PSMA摄取增高的机制可能为肿瘤新生血管形成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The potential applications of Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT in the imaging of prostate cancer are now well established. A few case reports regarding the potential use of Ga-PSMA PET/CT in nonprostate cancer malignancies are also published. Apparently, the tumor neoangiogenesis is the mechanism attributed to increased Ga-PSMA uptake in the tumor sites in nonprostatic malignancies. We describe the use of Ga-PSMA PET/CT in imaging multiple myeloma. The intense Ga-PSMA avidity of the lesions also opens up the possibility of theranostics with Lu-PSMA.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Sasikumar A, Joy A, Pillai MR, et al. 68Ga-PSMA PET/CT Imaging in Multiple Myeloma. Clin Nucl Med. 2017. PMID: 27941377. doi:10.1097/RLU.0000000000001479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。